NASDAQ:NOTV - Nasdaq - US45783Q1004 - Common Stock - Currency: USD
INOTIV INC
NASDAQ:NOTV (2/4/2025, 8:00:01 PM)
Premarket: 4.45 -0.04 (-0.89%)4.49
+0.06 (+1.35%)
The current stock price of NOTV is 4.49 USD. In the past month the price decreased by -10.74%. In the past year, price decreased by -9.48%.
WEST LAFAYETTE, Ind., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research...
WEST LAFAYETTE, Ind., Dec. 30, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization...
WEST LAFAYETTE, Ind., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization...
WEST LAFAYETTE, Ind., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization...
WEST LAFAYETTE, Ind., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization...
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
TMO | THERMO FISHER SCIENTIFIC INC | 26.56 | 222.07B | ||
DHR | DANAHER CORP | 28.71 | 155.30B | ||
A | AGILENT TECHNOLOGIES INC | 27.8 | 41.93B | ||
IQV | IQVIA HOLDINGS INC | 18.42 | 36.31B | ||
MTD | METTLER-TOLEDO INTERNATIONAL | 35.12 | 28.27B | ||
WAT | WATERS CORP | 36.03 | 24.37B | ||
WST | WEST PHARMACEUTICAL SERVICES | 48.97 | 23.97B | ||
ILMN | ILLUMINA INC | 71.79 | 19.70B | ||
ICLR | ICON PLC | 13.78 | 15.96B | ||
RVTY | REVVITY INC | 25.13 | 14.99B | ||
AVTR | AVANTOR INC | 22.46 | 14.98B | ||
TECH | BIO-TECHNE CORP | 40.53 | 11.53B |
Inotiv, Inc. is a pharmaceutical development company, which engages in the provision of nonclinical and analytical drug discovery and development services primarily to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to academia and government clients. The company is headquartered in West Lafayette, Indiana and currently employs 1,955 full-time employees. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. The company operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DSA segment supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. The RMS segment offer access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.
INOTIV INC
2701 Kent Ave
West Lafayette INDIANA 47906 US
CEO: Robert W. Leasure Jr.
Employees: 1955
Company Website: https://www.inotivco.com/
Investor Relations: https://www.basinc.com/invest
Phone: 13174634527
The current stock price of NOTV is 4.49 USD.
The exchange symbol of INOTIV INC is NOTV and it is listed on the Nasdaq exchange.
NOTV stock is listed on the Nasdaq exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for NOTV, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of NOTV.
NOTV does not pay a dividend.
NOTV will report earnings on 2025-02-05, after the market close.
NOTV does not have a PE ratio as the earnings reported over the last twelve months were negative (-4.19).
The outstanding short interest for NOTV is 5.37% of its float.
ChartMill assigns a technical rating of 7 / 10 to NOTV. When comparing the yearly performance of all stocks, NOTV is one of the better performing stocks in the market, outperforming 84.05% of all stocks.
ChartMill assigns a fundamental rating of 2 / 10 to NOTV. NOTV may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months NOTV reported a non-GAAP Earnings per Share(EPS) of -4.19. The EPS decreased by -1.95% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -13.88% | ||
ROE | -63.6% | ||
Debt/Equity | 2.29 |
ChartMill assigns a Buy % Consensus number of 80% to NOTV. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 40.24% and a revenue growth 8.01% for NOTV